Method for post coital contraception in overweight or obese female subjects using ulipristal acetate

Abstract

The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.

What is claimed is: 
     
         1 . A method for providing emergency contraception, comprising the step of administering to a woman about 30 mg of ulipristal acetate by oral route after an unprotected intercourse, wherein the woman is overweight having as body mass index (BMI) between about 25 and about 30. 
     
     
         2 . The method of  claim 1 , wherein ulipristal acetate is administered within about 72 hours after unprotected intercourse. 
     
     
         3 . The method of  claim 1 , wherein ulipristal acetate is administered within about 120 hours after unprotected intercourse. 
     
     
         4 . The method of  claim 1 , wherein ulipristal acetate is administered as an oral dosage form. 
     
     
         5 . The method of  claim 4 , wherein the oral dosage form is a tablet. 
     
     
         6 . A method for providing emergency contraception, comprising the step of administering to a woman about 30 mg of ulipristal acetate by oral route within about 120 hours after an unprotected intercourse, wherein the woman is overweight having a body mass index (BMI) between about 25 and about 30. 
     
     
         7 . The method of  claim 6 , wherein ulipristal acetate is administered within about 72 hours after unprotected intercourse. 
     
     
         8 . The method of  claim 6 , wherein ulipristal acetate is administered as an oral dosage form. 
     
     
         9 . The method of  claim 8 , wherein the oral dosage form is as tablet.